AAPG

MKT CAP:$2B

Ascentage Pharma Group International

Market Cap

$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$17.12-$9.25 (-35.08%)

Jun 8, 2026

52W High $47.9052W Low $17.12

Company Details

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a...

CEO

—

IPO Date

Jan 24, 2025

Website

www.ascentage.cn

Key Metrics TTM (CNY)

Revenue

¥1.1B

-28.0% YoY

Net Income

-¥2.4B

EPS (Diluted)

Free Cash Flow

-¥1.3B

Revenue / Share

¥11.43

Gross Margin

83.7%

Operating Margin

-226.9%

Net Margin

-230.4%

FCF Margin

-126.5%

P/S

P/E

Earnings Reports

Q2 2026

Aug 19, 2026

PENDING

Q1 2026

Apr 29, 2026

¥334M+113.0%

FY 2025

Mar 26, 2026

¥558M-43.1%

Q4 2025

Mar 26, 2026

¥334M+113.0%

Q2 2025

Aug 7, 2025

¥234M-71.6%

Revenue & Profitability (CNY)

Operating Cash Flow (CNY)

CapEx Spend (CNY)

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation (CNY)

OpEx Breakdown (CNY)

War Chest (CNY)

Shares Outstanding

Revenue Per Employee (CNY)

Revenue / Employee